MyAllies News
Breaking
Regulatory
World
Technology
Business
Politics
Entertainment
Health
Sports
Topics
mrD-negative
The latest news about mrD-negative: headlines, AI summaries and the full story from every source.
Immix Biopharma Reports 95% Complete Response Rate in Relapsed/Refractory AL Amyloidosis Trial
GlobeNewsWire ยท
May 21, 2026, 10:00 UTC